Summary
We are seeking a highly motivated Postdoctoral Researcher to join our interdisciplinary team focusing on the development, optimization, and scale-up of IgA antibody production platforms. This position combines efforts from PHARMIgA and Oncode Accelerator to advance next-generation antibodies for therapeutic applications.
Postdoctoral Researcher in IgA-Like Antibody Development, UMC Utrecht, Netherlands
Designation
Postdoctoral Researcher
Table
| Parameter | Details |
|---|---|
| Research Area | Antibody Development, Immunology, Biotechnology |
| Location | Utrecht, Netherlands |
| Salary | €3,598 – €5,669 gross per month |
| Employment Type | Fixed-term, full-time (36 hours) |
| Closing Date for Applications | 04 June 2026 |
Eligibility/Qualification
- PhD in antibody science, protein engineering, immunology, biotechnology, or a related field.
- At least 2 years of relevant experience in academia and/or industry following PhD completion.
- Strong background in immunology and antibody development, with experience in protein engineering and biologics development preferred.
- Hands-on experience with recombinant antibody production and purification is highly desirable.
- Knowledge of translational drug development or preclinical therapeutic development is considered advantageous.
- Ability to work independently and collaboratively in multidisciplinary teams.
- Strong analytical and problem-solving skills with a proactive mindset.
- Excellent communication skills in written and spoken English.
Job Description
The postdoctoral researcher will contribute to the PHARMIgA research program, primarily focusing on:
- Discovery and characterization of IgA antibodies.
- Production and manufacturing, aimed at improving and scaling IgA formats.
- Safety and efficacy testing through advanced human-relevant preclinical models.
- Delivery technologies, including novel administration methods.
Additionally, the role involves working on a demonstrator project within the Oncode Accelerator for developing a bispecific antibody that engages neutrophils to target cancer cells. The position is embedded in the Antibody Therapy group led by Prof. Jeanette Leusen, consisting of a collaborative team of researchers.
How to Apply
Interested candidates should contact Prof. Jeanette Leusen for inquiries and to submit their applications.
- Contact Number: 06 27 74 43 65
- Email: [Contact via email for details]
Last Date for Apply
04 June 2026
